![Danny Zanardo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 302 763 $ au 31/05/2026
Danny Zanardo is currently the Chief Commercial Officer at LTR Pharma Ltd. Previously, he worked as a Sales Director at Anteris Technologies Ltd. from 2011 to 2015.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LTR PHARMA LIMITED 0,62 % | 24/07/2025 | 1 122 135 ( 0,62 % ) | 302 763 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| LTR PHARMA LIMITED | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
Anteris Technologies Ltd.
 Anteris Technologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes technologies for heart valves | Sales & Marketing | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Anteris Technologies Ltd.
Anteris Technologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes technologies for heart valves | Health Technology |
Ltr Pharma Ltd.
 Ltr Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
